Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Myung-Ho | - |
dc.contributor.author | Oh, Chang-Hyun | - |
dc.date.accessioned | 2024-01-20T22:30:37Z | - |
dc.date.available | 2024-01-20T22:30:37Z | - |
dc.date.created | 2021-08-31 | - |
dc.date.issued | 2008-11-20 | - |
dc.identifier.issn | 0253-2964 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/132974 | - |
dc.description.abstract | The synthesis of a new series of diaryl ureas having a pyrrolo[2,3-d]pyrimidine scaffold is reported here. The in vitro antiproliferative activities of these diaryl derivatives against human melanoma cell line A375 were tested and the effect of substituents on the phenyl ring was investigated. The para substituted compounds la-g showed superior or similiar activity to Sorafenib against the A375 cell line. Among these compounds, Ic-e showed excellent activity against 375 compared with Sorafenib, a multi-kinase inhibitor. | - |
dc.language | English | - |
dc.publisher | WILEY-V C H VERLAG GMBH | - |
dc.subject | REFRACTORY SOLID TUMORS | - |
dc.subject | FACTOR RECEPTOR INHIBITOR | - |
dc.subject | RAF KINASE INHIBITORS | - |
dc.subject | PHASE-I | - |
dc.subject | BAY-43-9006 | - |
dc.subject | PHARMACOKINETICS | - |
dc.subject | THERAPY | - |
dc.subject | PATHWAY | - |
dc.subject | SAFETY | - |
dc.subject | UREAS | - |
dc.title | Synthesis and Antiproliferative Activities of Pyrrolo[2,3-d]pyrimidine Derivatives for Melanoma Cell | - |
dc.type | Article | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BULLETIN OF THE KOREAN CHEMICAL SOCIETY, v.29, no.11, pp.2231 - 2236 | - |
dc.citation.title | BULLETIN OF THE KOREAN CHEMICAL SOCIETY | - |
dc.citation.volume | 29 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 2231 | - |
dc.citation.endPage | 2236 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.identifier.kciid | ART001525660 | - |
dc.identifier.wosid | 000262091500029 | - |
dc.identifier.scopusid | 2-s2.0-57349106093 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | REFRACTORY SOLID TUMORS | - |
dc.subject.keywordPlus | FACTOR RECEPTOR INHIBITOR | - |
dc.subject.keywordPlus | RAF KINASE INHIBITORS | - |
dc.subject.keywordPlus | PHASE-I | - |
dc.subject.keywordPlus | BAY-43-9006 | - |
dc.subject.keywordPlus | PHARMACOKINETICS | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | PATHWAY | - |
dc.subject.keywordPlus | SAFETY | - |
dc.subject.keywordPlus | UREAS | - |
dc.subject.keywordAuthor | Pyrrolo[2,3-d]pyrimidine | - |
dc.subject.keywordAuthor | A375 | - |
dc.subject.keywordAuthor | Antiproliferative activity | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.